Latest News On FDA

Latest California Healthline Stories

FTC Has Long Said Products Must Back Up Health Claims. A MAHA Lawsuit Would Upend That.

Xlear, a maker of xylitol gum, has sued the Federal Trade Commission, saying the onus should be on government to prove that ingredients don’t live up to advertised claims. RFK Jr.’s “medical freedom” allies have rallied to the cause.

KFF Health News' 'What the Health?': Trump Further Politicizes Science

President Donald Trump’s latest executive order about science and medicine seeks to take funding decisions out of the hands of career scientists and give them to political appointees instead. And a gunman, reportedly disgruntled over covid vaccines, shoots at the headquarters of the Centers for Disease Control and Prevention, killing a law enforcement officer. Alice Miranda Ollstein of Politico, Shefali Luthra of The 19th, and Sarah Karlin-Smith of the Pink Sheet join KFF Health News’ Julie Rovner to discuss these stories and more. Also this week, Rovner interviews Aaron Carroll, president and CEO of the health services research group AcademyHealth, about how to restore the public’s trust in public health.

Listen: Regulatory Rollbacks and Federal Layoffs Threaten America’s Food Supply

The Trump administration’s anti-regulatory approach and cost-cutting moves risk unraveling the system of checks and balances that helps ensure the safety of the U.S. food supply, say consumer advocates and former employees of the FDA and Department of Agriculture.

KFF Health News' 'What the Health?': Kennedy Cancels Vaccine Funding

The Health and Human Services secretary is winding down nearly $500 million in mRNA research funding, citing false claims that the technology is ineffective against respiratory illnesses — and notching a victory for critics of the covid vaccines. And President Donald Trump is demanding drugmakers drop their prices, quickly, but it’s unclear how he could make them comply. Lauren Weber of The Washington Post, Sandhya Raman of CQ Roll Call, and Sarah Karlin-Smith of the Pink Sheet join KFF Health News’ Emmarie Huetteman to discuss these stories and more.

Aclarando la confusión sobre las vacunas contra covid-19

Las agencias dentro del Departamento de Salud y Servicios Sociales responsables de especificar quién debe vacunarse no están necesariamente sincronizadas, emitiendo recomendaciones en apariencia contradictorias.

KFF Health News' 'What the Health?': Next on Kennedy’s List? Preventive Care and Vaccine Harm

Robert F. Kennedy Jr., the secretary of Health and Human Services, is eyeing an overhaul of two more key entities as part of his ongoing effort to reshape health policy. And President Donald Trump signed an executive order last week that would enable localities to force some homeless people into residential treatment. Anna Edney of Bloomberg News, Joanne Kenen of the Johns Hopkins Bloomberg School of Public Health and Politico Magazine, and Shefali Luthra of The 19th join KFF Health News’ Julie Rovner to discuss these stories and more. Also, Rovner interviews Sara Rosenbaum, one of the nation’s leading experts on Medicaid, to mark Medicaid’s 60th anniversary this week.

KFF Health News' 'What the Health?': Here Come the ACA Premium Hikes

Medicaid may have monopolized Washington’s attention lately, but big changes are coming to the Affordable Care Act as well. Meanwhile, Americans are learning more about what’s in Trump’s big budget law, and polls suggest many don’t like what they see. Julie Appleby of KFF Health News, Jessie Hellmann of CQ Roll Call, and Alice Miranda Ollstein of Politico join KFF Health News’ Julie Rovner to discuss these stories and more. Also this week, Rovner interviews historian Jonathan Oberlander to mark Medicare’s 60th anniversary.

KFF Health News' 'What the Health?': The Senate Saves PEPFAR Funding — For Now

The Senate narrowly approved the Trump administration’s request to claw back about $9 billion for foreign aid and public broadcasting but refused to cut funding for the international AIDS/HIV program PEPFAR. Meanwhile, a federal appeals court ruled that West Virginia can ban the abortion pill mifepristone, which could allow states to block other FDA-approved drugs. Joanne Kenen of the Johns Hopkins Bloomberg School of Public Health and Politico Magazine, Shefali Luthra of The 19th, and Sandhya Raman of CQ Roll Call join KFF Health News’ Julie Rovner to discuss these stories and more.